A single case reports thrombocytopenia with thrombosis syndrome (TTS) following the mRNA-1273 vaccine for COVID-19. Previously, it was hypothesized that adenoviral vector-based vaccines were the sole cause of TTS or vaccine-induced ...
Jun 29, 2021
0
2
The ChAdOx1 COVID-19 vaccine is associated with a small increased risk for idiopathic thrombocytopenic purpura (ITP), according to a study published online June 9 in Nature Medicine.
Jun 18, 2021
0
8
Scientists the world over are scrambling to perfect an anti-viral treatment for the novel coronavirus, and following what might seem to be some unusual trails.
May 8, 2020
0
771
Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies—a multitude of painful blockages in small blood ...
Sep 4, 2019
0
2
(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).
Feb 7, 2019
0
3
(HealthDay)—There is an increased risk of developing cardiovascular disease (CVD) among patients with idiopathic thrombocytopenic purpura (ITP), especially those who undergo splenectomy, according to a study published online ...
Jan 9, 2018
0
4
(HealthDay)—U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura ...
Aug 24, 2015
0
5
Platelets are an expensive biomedical commodity. These microscopic cells that come to the rescue when our blood vessels need to be repaired cannot be frozen and are stable for only three to five days at room temperature.
Sep 26, 2014
0
0
A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of ...
May 7, 2012
0
1
